Rare diseases
Investigational molecules
Locations
Back to Czechia53 clinical trials in Brandys Nad Labem, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaStudy of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
CzechiaStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
CzechiaStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
CzechiaCzechiaStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
CzechiaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
CzechiaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
CzechiaPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
CzechiaA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
CzechiaRO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Research focusing on chronic respiratory conditions, particularly investigating new treatments for COPD and asthma. Studies evaluate innovative therapies aimed at improving lung function and reducing disease exacerbations.
Multiple trials exploring combination therapies and novel compounds for better disease control.
Comprehensive research into heart disease prevention and treatment, including studies on heart failure, atrial fibrillation, and atherosclerotic cardiovascular disease.
Investigation of innovative medications targeting various aspects of cardiovascular health.
Studies examining treatments for Type 2 diabetes and related metabolic conditions, with a focus on cardiovascular outcomes and weight management.
Evaluation of new therapeutic approaches combining multiple treatment mechanisms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
